Literature DB >> 6242467

T-lymphocyte clones.

C G Fathman, J G Frelinger.   

Abstract

To date, the most successful uses of T-cell clones have been in the demonstration that a single type of cell can perform multiple functions. However, their potential usefulness is enormous, and the study of cell interactions using clonal populations has just begun. The development and study of more cloned populations will surely lead to a clearer analysis of cellular interactions in the immune system. The use of T-cell clones and hybridomas to analyze T-cell receptors and/or factors is well under way, and will continue to be an area of intense investigation. Molecular biologists will undoubtedly make more extensive use of T-cell clones in the future, both as a source of cloning material and as transfection recipients. The most exciting area for development, from a medical point of view, is the potential for use of these cell lines or their products in immunotherapy and in providing a mechanism for specifically modulating the immune response.

Mesh:

Substances:

Year:  1983        PMID: 6242467     DOI: 10.1146/annurev.iy.01.040183.003221

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  11 in total

1.  Mechanisms of genetic control of immune responses. II. Nonresponsiveness in BALB/c GT-specific cell-mediated immune responses does not correlate with the absence of functional T cells or the induction of suppressor T cells.

Authors:  M K Kennedy; M K Jenkins; S D Miller
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell clone.

Authors:  J E Hambor; C A Hauer; H K Shu; R K Groger; D R Kaplan; M L Tykocinski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

3.  Antigen presentation by a B-cell line transfected with cloned immunoglobulin heavy- and light-chain genes specific for a defined hapten.

Authors:  M Watanabe; D R Wegmann; A Ochi; N Hozumi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice.

Authors:  Saori Nakagawa; Koji Kushiya; Ikue Taneike; Ken'ichi Imanishi; Takehiko Uchiyama; Tatsuo Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

5.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.

Authors:  P A Morel; J S Dorman; J A Todd; H O McDevitt; M Trucco
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  A human T cell clone that mediates the monocyte procoagulant response to specific sensitizing antigen.

Authors:  B S Schwartz; P J Reitnauer; J A Hank; P M Sondel
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

7.  Extensive diversity in the recognition of influenza virus hemagglutinin by murine T helper clones.

Authors:  K H Mills; J J Skehel; D B Thomas
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

8.  Clonal expansion of human T lymphocytes initiated by dendritic cells.

Authors:  E Langhoff; R M Steinman
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

9.  Antigen recognition by a T cell clone outside the context of the major histocompatibility complex. A role for Mls in antigen presentation.

Authors:  S J Waters; S D Waksal; G P Norton; C A Bona
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

Review 10.  Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.

Authors:  Arata Itoh; William M Ridgway
Journal:  Immunotargets Ther       Date:  2017-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.